| Otsuka Pharmaceutical (Switzerland) GmbH - Jinarc 30 mg, Tabletten |
| 65676 | | 02 | | Jinarc 30 mg | | Tabletten | | C03XA01 | | Tolvaptan | | 21.04.2016 | | |
|
| Composition |
| tolvaptanum 30 mg, hydroxypropylcellulosum, lactosum monohydricum 73.826 mg, maydis amylum, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, magnesii stearas, E 132 pro compresso. |
| Packungsbestandteile |
| Tablets | | | | | Active Agent | Dose |
|---|
| Tolvaptanum | 30 mg |
| | BAG: Active Agent | Dose |
|---|
| Tolvaptanum | 30 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Cellulosum Microcristallinum | | | | E 132 | | color. | | Hydroxypropylcellulosum | | | | Hydroxypropylcellulosum Substitutum Humile | | | | Lactose Monohydrate | 73.826 mg | | | Magnesii Stearas | | | | Maydis Amylum | | | | Pro Compresso | | |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 004 | 28 | 1288.92 | 1418.20 | A | SL | Yes |
|
